PF-03654764

DB12360InvestigationalSmall molecule

PF-03654764 has been used in trials studying the basic science and treatment of Allergic Rhinitis.

Chemical structure of PF-03654764
Mechanism
Curator reviewed
Formula / weight
C20H28F2N2O · 350.454 g/mol (avg)
Code names
PF-03654764

Resolves to

Compound
UNIIFPI2G03BJ1CAS935840-35-0ChEMBLCHEMBL2206292PubChem16119082
Structure
InChIKeyDJRDLCHHQYHQQK-UKIBZPOASA-NSMILESCC(C)CNC(=O)[C@H]1C[C@](F)(C1)C1=CC(F)=C(CN2CCCC2)C=C1
Targets
Q9Y5N1HRH3

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with PF-03654764, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In